These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
403 related items for PubMed ID: 15138523
21. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan. Tseng HF, Chang CK, Tan HF, Yang SE, Chang HW. Vaccine; 2006 Jul 17; 24(29-30):5772-7. PubMed ID: 16759764 [Abstract] [Full Text] [Related]
22. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran. Soleimanjahi H, Bamdad T, Fotouhi F, Roustai MH, Faghihzadeh S. J Clin Virol; 2005 Oct 17; 34(2):153-4. PubMed ID: 16076562 [Abstract] [Full Text] [Related]
23. Rubella outbreak on Tokunoshima Island in 2004: serological and epidemiological analysis of pregnant women with rubella. Kaneko M, Sameshima H, Ikenoue T, Minematsu T, Kusumoto K, Ibara S, Kamitomo M, Maruyama Y. J Obstet Gynaecol Res; 2006 Oct 17; 32(5):461-7. PubMed ID: 16984512 [Abstract] [Full Text] [Related]
24. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems. Braito A, Fanti O, Rossolini GM, Cellesi C. Boll Ist Sieroter Milan; 2006 Oct 17; 70(1-2):443-8. PubMed ID: 1670047 [Abstract] [Full Text] [Related]
25. Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data. Artimos de Oliveira S, Bastos Camacho LA, Uzeda Barreto MC, Coca Velarde LG, Siqueira MM. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S664-8. PubMed ID: 21954264 [Abstract] [Full Text] [Related]
26. Seroprevalence of rubella among Turkish women and children in Afyonkarahisar, Turkey. Demirdal T, Demirtürk N, Toprak D, Aktepe OC, Aşci Z. Turk J Pediatr; 2009 Sep 01; 51(6):534-8. PubMed ID: 20196385 [Abstract] [Full Text] [Related]
27. Postinfection and postvaccination antirubella immunity. Kańtoch M, Imbs D. Acta Virol; 1986 Sep 01; 30(5):381-9. PubMed ID: 2878585 [Abstract] [Full Text] [Related]
28. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey. Ocak S, Zeteroglu S, Ozer C, Dolapcioglu K, Gungoren A. Scand J Infect Dis; 2007 Sep 01; 39(3):231-4. PubMed ID: 17366053 [Abstract] [Full Text] [Related]
29. Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes. Kakoulidou M, Forsgren M, Lewensohn-Fuchs I, Johansen K. Vaccine; 2010 Jan 22; 28(4):1002-7. PubMed ID: 19925909 [Abstract] [Full Text] [Related]
30. Clinical rubella reinfection during pregnancy in a previously vaccinated woman. Aboudy Y, Barnea B, Yosef L, Frank T, Mendelson E. J Infect; 2000 Sep 22; 41(2):187-9. PubMed ID: 11023770 [Abstract] [Full Text] [Related]
31. Rubella vaccination of unknowingly pregnant women during 2006 mass campaign in Argentina. Pardon F, Vilariño M, Barbero P, Garcia G, Outon E, Gil C, Vera A, Rossi S, Distefano A. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S745-7. PubMed ID: 21954276 [Abstract] [Full Text] [Related]
32. [Avidity of immunoglobulin G to rubella virus in post-vaccination and post-infection immunity]. Desiatskova RG, Zargar'iants AI, Stepanov AV, Zverev VV. Zh Mikrobiol Epidemiol Immunobiol; 2007 Sep 01; (4):6-11. PubMed ID: 17882830 [Abstract] [Full Text] [Related]
33. Seroepidemiological survey of rubella immunity among three populations in Shiraz, Islamic Republic of Iran. Doroudchi M, Dehaghani AS, Emad K, Ghaderi AA. East Mediterr Health J; 2001 Sep 01; 7(1-2):128-38. PubMed ID: 12596962 [Abstract] [Full Text] [Related]
34. Pregnancy outcomes following rubella vaccination: a prospective study in the state of Rio de Janeiro, Brazil, 2001-2002. da Silva e Sá GR, Camacho LA, Stavola MS, Lemos XR, Basílio de Oliveira CA, Siqueira MM. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S722-8. PubMed ID: 21954273 [Abstract] [Full Text] [Related]
35. Seroprevalence of rubella antibodies among antenatal population attending a tertiary level hospital in Dhaka City. Ashrafunnessa, Khatun S, Islam MN, Chowdhury S. Bangladesh Med Res Counc Bull; 2000 Dec 01; 26(3):75-81. PubMed ID: 11766002 [Abstract] [Full Text] [Related]
36. [Sero-epidemiological survey of virus infections in pregnant women of the Changchun district]. Yue J. Zhonghua Fu Chan Ke Za Zhi; 1990 Sep 01; 25(5):269-71, 315. PubMed ID: 2178080 [Abstract] [Full Text] [Related]
37. Seroprevalence of rubella antibodies among pregnant females in Sri Lanka. Palihawadana P, Wickremasinghe AR, Perera J. Southeast Asian J Trop Med Public Health; 2003 Jun 01; 34(2):398-404. PubMed ID: 12971571 [Abstract] [Full Text] [Related]
38. Does rubella immunity predict measles immunity? A serosurvey of pregnant women. Kennedy CM, Burns BA, Ault KA. Infect Dis Obstet Gynecol; 2006 Jun 01; 2006():13890. PubMed ID: 17485795 [Abstract] [Full Text] [Related]
39. Factors associated with low immunity to rubella infection on antenatal screening. Sathanandan D, Gupta L, Liu B, Rutherford A, Lane J. Aust N Z J Obstet Gynaecol; 2005 Oct 01; 45(5):435-8. PubMed ID: 16171483 [Abstract] [Full Text] [Related]
40. Immune status of health care personnel & post vaccination analysis of immunity against rubella in an eye hospital. Rajasundari TA, Chandrasekar K, Vijayalakshmi P, Muthukkaruppan V. Indian J Med Res; 2006 Nov 01; 124(5):553-8. PubMed ID: 17213524 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]